Safety study of KT-579 in healthy volunteers
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult.
- Your weight must be at least 110 pounds (50 kg) if male or 88 pounds (40 kg) if female.
- Your body mass index (BMI) must be between 18 and 32.
- You must not have any major medical conditions or take certain medications.
- You must agree to use birth control (if applicable) and not donate sperm or eggs during the study.
- You cannot be pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new tablet called KHN707 in healthy volunteers. Researchers want to understand how the body processes the drug and check for any side effects.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new tablet called KHN702 in healthy people to see how safe it is and how the body processes it. It helps researchers understand the right dose and any side effects before moving to larger studies.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.